Principal Financial Group Inc Lexicon Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

$162 Billion
Q1 2024

A detailed history of Principal Financial Group Inc transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 10,534 shares of LXRX stock, worth $17,591. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,534

Previous 10,534 -0.0%

Holding current value

$17,591

Previous $16,000 56.25%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$1.0 - $1.53 $201 - $307	201 Added 1.95%	10,534 $16,000
Q2 2023 Aug 07, 2023	SELL	$2.15 - $3.49 $64,953 - $105,436	-30,211 Reduced 74.51%	10,333 $23,000
Q1 2023 May 09, 2023	SELL	$1.99 - $2.68 $1,327 - $1,787	-667 Reduced 1.62%	40,544 $98,000
Q4 2022 Feb 09, 2023	BUY	$1.8 - $2.56 $56,169 - $79,884	31,205 Added 311.86%	41,211 $78,000
Q3 2022 Nov 09, 2022	BUY	$1.94 - $3.43 $19,411 - $34,320	10,006 New	10,006 $24,000

Q2 2022 Aug 10, 2022	SELL	$1.31 - $2.69 $67,930 - $139,489	-51,855 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$1.95 - $3.89 $36,921 - $73,653	-18,934 Reduced 26.75%	51,855 $108,000
Q4 2021 Feb 09, 2022	SELL	$3.81 - $6.16 $467,193 - $755,357	-122,623 Reduced 63.4%	70,789 $279,000
Q3 2021 Nov 09, 2021	SELL	$3.38 - $5.35 $19,840 - $31,404	-5,870 Reduced 2.95%	193,412 $930,000
Q2 2021 Aug 10, 2021	BUY	$4.12 - $5.87 $71,770 - $102,255	17,420 Added 9.58%	199,282 $914,000
Q1 2021 May 10, 2021	BUY	$3.45 - $9.09 $45,629 - $120,224	13,226 Added 7.84%	181,862 $1.07 Million
Q4 2020 Feb 08, 2021	BUY	$1.05 - $3.67 $39,061 - $136,527	37,201 Added 28.3%	168,636 $577,000
Q3 2020 Nov 06, 2020	BUY	$1.44 - $2.1 $89,562 - $130,611	62,196 Added 89.83%	131,435 $189,000
Q2 2020 Aug 05, 2020	BUY	$1.75 - $2.3 $121,168 - $159,249	69,239 New	69,239 $138,000
Q4 2019 Feb 05, 2020	SELL	$3.16 - $5.15 $49,817 - $81,189	-15,765 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$1.2 - $6.66 $610 - $3,389	-509 Reduced 3.13%	15,765 $47,000
Q2 2019 Aug 12, 2019	BUY	$5.35 - $7.11 $3,226 - $4,287	603 Added 3.85%	16,274 $102,000
Q1 2019 May 10, 2019	BUY	$4.36 - $7.94 $2,084 - $3,795	478 Added 3.15%	15,671 $87,000
Q4 2018 Feb 14, 2019	SELL	$6.15 - $10.51 $6,697 - $11,445	-1,089 Reduced 6.69%	15,193 $101,000
Q3 2018 Nov 14, 2018	BUY	$10.32 - $13.06 $7,977 - $10,095	773 Added 4.98%	16,282 $174,000
Q2 2018 Aug 13, 2018	SELL	$7.8 - $13.69 $27,050 - $47,476	-3,468 Reduced 18.27%	15,509 $0
Q1 2018 May 14, 2018	BUY	$7.86 - $11.39 $13,204 - $19,135	1,680 Added 9.71%	18,977 $163,000
Q4 2017 Feb 13, 2018	BUY	$8.77 - $12.28 $151,694 - $212,407	17,297	17,297 $171,000

Others Institutions Holding LXRX

# of Institutions

122

Shares Held

159M

Call Options Held

2.11M

Put Options Held

412K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $315M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Lexicon Pharmaceuticals, Inc. Transaction History